Member Info for DanRey

Well hasn’t moved the price so nothing that has enthralled the market I surmise.

Absolutely. Just want to break even.

Well sadly the video seems to have had little impact on the market or any new investors buying in. At least they are trying to get the OCTP noticed which is more than most companies.

You would have to own over 39 million shares for a tr1 now. With all these placings never have any holders with that larger interest. Soon Vlad will be exempt from declaring an interest.

Mr India. I don’t see why we would hear any information before Easter break.

I wonder if they will be announced shortly after Easter. Although the USA is a Private Health setting I am sure like the NHS consultants and senior medical staff will be off during the holidays and there would be no point in breaking any analysis due to staff availability. Just a thought.

Dhub greed will always come above Health. People to often don’t realise in life that if you or your loved ones don’t have it then everything else is worthless.

Tick up! Hopefully more of the Long than the Short of it moving forward.

Maybe it’s a sign!

Maybe it was someone bringing the price down to reduce the options and thus force negotiations. I sound like one of those conspiracy theorists!

Hopefully there will be as sudden reversal that benefits us long term holders who have remained hopeful on the clinical outcome while experiencing increasing dilution and its the shorters who get punished for a change.

Wonder how many would take a low offer just to break even?

You can buy up to 6million shares on Halifax before it goes to Negotiated settlement. I don’t know what the maximum sell is as I don’t have enough shares to achieve it . Can’t recall such large availability of shares to be able to buy since Mint.

Mr India They generally say companies get brought out when they have a product but there is not the confidence in management. Hemo share price to the potential of the product seems to show low market confidence. Maybe why shorting around this share has always been so active. Any rise on Scientific news is followed by a funding fall. Just how it seems.

Mr India I feel we are much more diluted than we should be. The company managed to raise at 7 around covid. Then there was the Mint disaster. No lessons were learned. Here we are. Great advance in Science but at a greater rate of dilution than I had hoped. I have always said the Science and the Money management should be separate. I know it’s Vlads company but surely when you list you are answerable to share holders.

Vlads Science is the Catalyst for a rise in price his business management seems to be a catalyst for its fall. Sadly the scales are firmly towards the latter.

Probably a sell I would guess. Maybe what has dragged the price down here. Positive sentiment seems low. Don’t suppose any forward buying ever occurs.

Being in Hemo has me feeling Minted again just not in a wealthy way. Oh well let’s see where the trials take us.

1.80 wasn’t the vision I had hoped for at this stage.

I only have myself to blame for continuing my unhealthy shareholding in Hemo. I have been here since pre covid and the same old same old happens constantly. I thought now we had crossed in to clinical we would have been able to raise higher. I thought at the time of the last 2 RNSs that was what Vlad/Hemo were trying to achieve to push up the price and raise at about 3+. Mint, constant smoke and mirror tweeting, my telling myself he’s a good Scientist not businessman, the battle between rampers and derampers (derampers seem to be proven right more often) rinse and repeat. Hope one day the record changes.